The combination of the nicotinamide/STZ model and HFD is valuable for studying the metabolic abnormalities associated with T2DM, including abnormal plasma glucose and insulin levels, disrupted lipid metabolism, the generation of oxidative stress, and liver dysfunction. The gene discussed is INS; the disease is type 2 diabetes mellitus.